首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Metabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic Targets
Authors:Yue Gong  Peng Ji  Yun-Song Yang  Shao Xie  Tian-Jian Yu  Yi Xiao  Ming-Liang Jin  Ding Ma  Lin-Wei Guo  Yu-Chen Pei  Wen-Jun Chai  Da-Qiang Li  Fan Bai  François Bertucci  Xin Hu  Yi-Zhou Jiang  Zhi-Ming Shao
Institution:1. Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, P.R. China;2. Laboratory Animal Center, Fudan University Shanghai Cancer Center, Shanghai 200032, P.R. China;3. Biomedical Pioneering Innovation Center (BIOPIC), School of Life Sciences, Peking University, Beijing 100871, P.R. China;4. Predictive Oncology Laboratory and Department of Medical Oncology, CRCM, Institut Paoli-Calmettes, INSERM, CNRS, Aix-Marseille Université, Marseille, France;5. Institute of Pediatrics, Children''s Hospital, Fudan University, Shanghai 201102, P.R. China;6. Precision Cancer Medicine Center, Fudan University Shanghai Cancer Center, Shanghai 200032, P.R. China
Abstract:
><ol class=
  • Download : Download high-res image (199KB)
  • Download : Download full-size image
  • Keywords:triple-negative breast cancer  metabolism  heterogeneity  metabolic pathway  subtype  glycolysis  metabolic inhibitor  immunotherapy  survival
    本文献已被 ScienceDirect 等数据库收录!
    设为首页 | 免责声明 | 关于勤云 | 加入收藏

    Copyright©北京勤云科技发展有限公司  京ICP备09084417号